The global PRP and PRF in cosmetics market set to grow as demand for minimally invasive aesthetic procedures rises. Patients and practitioners are increasingly adopting Platelet-Rich Plasma (PRP) and Platelet-Rich Fibrin (PRF) therapies in cosmetic dermatology. These biologically derived treatments rejuvenate skin and restore hair while minimising side effects.
Recent market analysis valued the global PRP and PRF in cosmetics market at US$ 207.6 million in 2024. Analysts project the market to grow at a robust CAGR of 12.3% between 2025 and 2035. By 2035, the market is expected to surpass US$ 732 million.
Dermatology clinics drive adoption
Demand is increasing as early skin aging and hair loss conditions rise worldwide. Dermatologists and clinics are adopting PRP/PRF treatments for wrinkle reduction, acne scar improvement, and overall skin revitalisation. Rising acceptance of regenerative medicine and stem-cell-based therapies is accelerating market adoption. Expanding investments in advanced dermatology clinics and R&D activities further strengthen this growth.
Expanding applications in cosmetics
Applications continue to diversify, with PRP and PRF being used for skin rejuvenation, facial aesthetics, scar management, hair regrowth, and under-eye treatments. In hair restoration, they stimulate dormant follicles and enhance thickness, offering a non-surgical alternative to transplants. In facial rejuvenation, they improve tone, elasticity, and texture, strengthening their position in cosmetic surgery centers.
Opportunities in combination therapies
Opportunities are also emerging in combination treatments. Clinical studies are exploring PRP and PRF alongside dermal fillers, microneedling, and laser therapy to amplify results. PRF, a second-generation platelet concentrate, shows promise by releasing growth factors longer, promoting lasting skin repair and regeneration.
Natural and autologous therapies gain ground
The shift toward natural, safe, and autologous therapies is further propelling demand. Because PRP and PRF are derived from a patient’s own blood, they minimise the risk of rejection or allergic reactions. This aligns with the broader clean beauty trend, where patients increasingly prefer biocompatible cosmetic options. Manufacturers are investing in advanced centrifugation technologies to improve platelet concentration, opening new pathways for innovation.
Growth outlook
North America, Europe, and Asia-Pacific continue to dominate as the most lucrative regions. Strong growth is expected in the U.S., Germany, the U.K., China, and India.The industry now examines the scale of growth expected by 2031 and the most promising application areas. Stakeholders also explore how to integrate PRP/PRF with next-generation cosmetic treatments.